Elite Pharmaceuticals, Inc. (ELTP) Gross profit 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) annual gross profit history from SEC filings — each fiscal year as reported.
$75.0MFY2026 · since FY2017: $3.7M → $75.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $75.0M | +87.2% |
| FY2025 | $40.1M | +52.1% |
| FY2024 | $26.4M | +58.8% |
| FY2023 | $16.6M | +12.2% |
| FY2022 | $14.8M | +24.7% |
| FY2021 | $11.9M | +48.7% |
| FY2020 | $8.0M | +178.2% |
| FY2019 | $2.9M | -27.4% |
| FY2018 | $3.9M | +5.6% |
| FY2017 | $3.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice